Green Lifescience Co., Ltd. (KOSDAQ:114450)

Green Lifescience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8,745	9,068	6,348	2,814	3,388	2,402
Short-Term Investments	-	127.56	5,669	2,300	7,800	7,800
Trading Asset Securities	3,767	3,690	2,436	11,835	5,015	4,930
Cash & Short-Term Investments	12,512	12,885	14,453	16,949	16,203	15,133
Cash Growth	1.91%	-10.85%	-14.73%	4.60%	7.08%	-26.21%
Accounts Receivable	2,312	4,997	1,451	2,509	3,450	1,753
Other Receivables	151.75	38.99	8.54	333.75	114.13	284.56
Receivables	2,463	5,036	1,460	2,843	3,564	2,037
Inventory	6,733	3,905	5,311	6,014	5,732	6,649
Prepaid Expenses	72	52.01	160.15	42.62	735.77	438.83
Other Current Assets	126.59	112.3	328.73	595.04	657.55	314.22
Total Current Assets	21,907	21,991	21,712	26,443	26,892	24,572
Property, Plant & Equipment	13,496	13,533	13,256	27,112	36,846	35,626
Long-Term Investments	-	-	-	-	7,381	9,912
Other Intangible Assets	2.1	97.47	2.81	87.92	181.72	370.26
Long-Term Deferred Tax Assets	-	-	-	-	619.37	355.14
Long-Term Deferred Charges	64.79	11.92	24.91	-	-	-
Other Long-Term Assets	9,340	9,339	8,833	8,788	57.44	12.08
Total Assets	44,811	44,972	43,828	62,432	71,977	70,846
Accounts Payable	3,466	-	-	-	4,114	2,835
Accrued Expenses	93.42	-	-	-	2.12	136.07
Short-Term Debt	4,800	4,800	4,800	6,488	7,433	6,211
Current Portion of Leases	14.8	41.01	104.04	117.85	104.86	170.18
Current Unearned Revenue	21.9	46.72	34	34	-	-
Other Current Liabilities	896.56	3,426	2,455	2,796	3,588	1,429
Total Current Liabilities	9,293	8,314	7,394	9,437	15,242	10,781
Long-Term Leases	513.41	530.9	28.82	18.27	57.76	31.42
Other Long-Term Liabilities	24.67	21.61	8.12	6.78	8.19	6.67
Total Liabilities	10,209	9,224	7,874	9,793	15,679	11,475
Common Stock	10,000	10,000	10,000	7,500	7,500	7,500
Additional Paid-In Capital	15,025	15,025	36,425	38,956	38,956	38,956
Retained Earnings	11,600	12,746	-10,105	6,232	9,680	12,820
Treasury Stock	-2,023	-2,023	-366.29	-	-	-
Comprehensive Income & Other	-0	-0	0	-48.7	162.39	95.97
Shareholders' Equity	34,602	35,748	35,954	52,639	56,298	59,371
Total Liabilities & Equity	44,811	44,972	43,828	62,432	71,977	70,846
Total Debt	5,328	5,372	4,933	6,624	7,595	6,413
Net Cash (Debt)	7,184	7,513	9,520	10,324	8,608	8,720
Net Cash Growth	-2.87%	-21.08%	-7.79%	19.93%	-1.28%	-42.80%
Net Cash Per Share	376.04	390.48	476.93	516.22	430.42	436.01
Filing Date Shares Outstanding	19.09	19.09	19.83	20	20	20
Total Common Shares Outstanding	19.09	19.09	19.83	20	20	20
Working Capital	12,615	13,677	14,319	17,007	11,651	13,791
Book Value Per Share	1812.81	1872.83	1812.66	2631.95	2814.92	2968.56
Tangible Book Value	34,600	35,650	35,951	52,551	56,117	59,001
Tangible Book Value Per Share	1812.70	1867.72	1812.52	2627.55	2805.83	2950.04
Land	8,450	8,450	8,425	8,329	7,923	7,923
Buildings	7,918	7,918	7,846	16,077	13,381	13,381
Machinery	35,771	35,677	35,434	38,766	39,913	37,596
Construction In Progress	55.99	-	23.1	207.03	11,769	10,758

Source: S&P Global Market Intelligence. Standard template. Financial Sources.